Literature DB >> 23354286

Response assessment methodologies in hepatocellular carcinoma: complexities in the era of local and systemic treatments.

Riad Salem, Frank H Miller, Vahid Yaghmai, Robert J Lewandowski.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23354286     DOI： 10.1016/j.jhep.2013.01.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

Review 1.  Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.

Authors:  Nathan X Chai; Julius Chapiro
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 2.  Lobar Radioembolization for Intermediate and Advanced Hepatocellular Carcinoma: Retrospective and Prospective Data.

Authors:  Janesh Lakhoo; Thomas H Perez; Anthony J Borgmann; Daniel B Brown
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

3.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Authors:  Riad Salem; Andrew C Gordon; Samdeep Mouli; Ryan Hickey; Joseph Kallini; Ahmed Gabr; Mary F Mulcahy; Talia Baker; Michael Abecassis; Frank H Miller; Vahid Yaghmai; Kent Sato; Kush Desai; Bartley Thornburg; Al B Benson; Alfred Rademaker; Daniel Ganger; Laura Kulik; Robert J Lewandowski
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

4.  Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.

Authors:  Michael Vouche; Laura Kulik; Rohi Atassi; Khairuddin Memon; Ryan Hickey; Daniel Ganger; Frank H Miller; Vahid Yaghmai; Michael Abecassis; Talia Baker; Mary Mulcahy; Ritu Nayar; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2013-10-01       Impact factor: 17.425

5.  The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.

Authors:  Lei Liu; Yan Zhao; Jia Jia; Hui Chen; Wei Bai; Man Yang; Zhanxin Yin; Chuangye He; Lei Zhang; Wengang Guo; Jing Niu; Jie Yuan; Hongwei Cai; Jielai Xia; Daiming Fan; Guohong Han
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

6.  Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis.

Authors:  Chao He; Wei Peng; Xiaojuan Liu; Chuan Li; Xueting Li; Tian-Fu Wen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.